Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

Clinical trial NCT02668666 · COMPLETED

Trial details

NCT number: NCT02668666
Sponsor: Oana Danciu, MD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Receptor Positive Malignant Neoplasm of Breast Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Estrogen Receptor Positive Breast Cancer Progesterone Receptor Positive Tumor Metastatic Breast Cancer

Start date: 2017-02-01
Primary completion: 2023-07-03
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.